Using periorbital massage to reduce nausea and vomiting after gallbladder surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of periorbital massage in alleviating postoperative nausea and vomiting in patients who have undergone laparoscopic cholecystectomy. Participants are divided into two groups, one receiving the massage and the other not receiving any intervention. The aim is to determine if this non-invasive technique can significantly reduce the incidence of nausea and vomiting following surgery. The study focuses on patients aged 18-70 who are undergoing this common surgical procedure.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Those who have laparoscopic cholecystectomy surgery under general anesthesia,

* Those between the ages of 18-70,
* Those who do not have a psychiatric disease,
* Those who understand what they read and volunteer patients,
* Those who do not have a hearing or speech problem,

Exclusion Criteria:

* Patients undergoing emergency surgery,

  * Patients with psychiatric disorders
  * Patients who have taken another antiemetic drug within 24 hours before surgery

Where it's running

• Tuğba Albayram
  Gaziantep, Turkey (Türkiye) Recruiting

Study contacts

• Study coordinator: çağla toprak
• Email: cagla.toprak@atlas.edu.tr
• Phone: 532 799 78 14

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• HR20013 for preventing nausea and vomiting in cancer patients receiving chemotherapy

  This real-world study tests whether HR20013 helps prevent nausea and vomiting in adults with cancer who are getting chemotherapy.

  Recruiting Sun Yat-sen University · Guangzhou, Guangdong · NCT07874308

• Olanzapine plus metoclopramide to prevent opioid-related nausea and vomiting

  This trial will test whether a one-week course of low-dose olanzapine plus metoclopramide prevents nausea and vomiting in adults with advanced cancer who are starting strong opioid painkillers.

  Recruiting Phase 3 Affiliated Hospital of Qinghai University · Xining, Qinghai · NCT07208305

• LY3537021 for preventing chemo-related nausea and vomiting in adults

  This trial will test whether adding LY3537021 to standard anti-nausea care helps prevent nausea and vomiting in adults starting AC or high-dose cisplatin chemotherapy.

  Recruiting at 58 sites Phase 2 Eli Lilly and Company · Greenbrae, California and 66 other locations · NCT07169851

• Treatment of marginal ulcers using low-thermal argon plasma

  This study is testing if a new low-thermal argon plasma treatment can help heal stubborn ulcers that some people get after weight loss surgery, to see if it works better than the usual medicine.

  Recruiting Brigham and Women's Hospital · Boston, Massachusetts · NCT06543316

• Using Enterra Therapy to Treat Chronic Nausea and Vomiting

  This study is testing whether the Enterra Therapy System can help people with chronic nausea and vomiting feel better and improve their quality of life.

  Recruiting at 22 sites Enterra Medical, Inc. · Scottsdale, Arizona and 21 other locations · NCT06464926

• Using Fosaprepitant to Treat Nausea and Vomiting

  This study is testing if a new medication called fosaprepitant can help people with nausea and vomiting feel better compared to the usual treatment they receive.

  Recruiting Phase 2/3 Montefiore Medical Center · The Bronx, New York · NCT06382012

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.